Insulet (PODD) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.06% |
| Dec 31, 2025 | -17.13% |
| Sep 30, 2025 | -68.25% |
| Jun 30, 2025 | -18.60% |
| Mar 31, 2025 | -25.91% |
| Dec 31, 2024 | -4.72% |
| Sep 30, 2024 | -34.50% |
| Jun 30, 2024 | 8.77% |
| Mar 31, 2024 | -38.83% |
| Dec 31, 2023 | 4.97% |
| Sep 30, 2023 | 3.22% |
| Jun 30, 2023 | 17.68% |
| Mar 31, 2023 | 5.54% |
| Dec 31, 2022 | 9.95% |
| Sep 30, 2022 | -69.98% |
| Jun 30, 2022 | 0.07% |
| Mar 31, 2022 | -2.09% |
| Dec 31, 2021 | 17.83% |
| Sep 30, 2021 | 22.99% |
| Jun 30, 2021 | 21.08% |
| Mar 31, 2021 | -77.49% |
| Dec 31, 2020 | -81.88% |
| Sep 30, 2020 | 18.87% |
| Jun 30, 2020 | 205.37% |
| Mar 31, 2020 | 38.43% |
| Dec 31, 2019 | -82.97% |
| Sep 30, 2019 | 42.74% |
| Jun 30, 2019 | -61.48% |
| Mar 31, 2019 | 40.75% |
| Dec 31, 2018 | -70.99% |
| Sep 30, 2018 | -70.97% |
| Jun 30, 2018 | -106.54% |
| Mar 31, 2018 | -120.71% |
| Dec 31, 2017 | -135.65% |
| Sep 30, 2017 | 21.00% |
| Jun 30, 2017 | -53.85% |
| Mar 31, 2017 | -90.20% |
| Dec 31, 2016 | -111.88% |
| Sep 30, 2016 | -68.89% |
| Jun 30, 2016 | 1.67% |
| Mar 31, 2016 | 20.13% |
| Dec 31, 2015 | -3.60% |
| Sep 30, 2015 | -34.48% |